A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/50 (2006.01) A61K 31/137 (2006.01)
Patent
CA 2645940
The invention encompasses stable multiparticulate pharmaceutical compositions of tolterodine having at least one pharmaceutically acceptable excipient and at least two populations of multiparticulates each population having tolterodine or a salt thereof and the ratio of the populations is from 90:10 to 10:90 by weight, wherein after storage for 1 month at 40 °C and 75 % relative humidity the difference between the dissolution profile at 4 hours is no more than about 5 % when compared to the dissolution profile at the time of manufacture.
La présente invention englobe des compositions pharmaceutiques stables multiparticulaires de toltérodine comportant au moins un excipient de qualité pharmaceutique et au moins deux populations de microparticules, chaque population comportant la toltérodine ou un sel de ce composé, le rapport des populations étant compris entre 90 : 10 et 10 : 90 en poids, la différence entre le profil de dissolution à 4 heures après stockage pendant 1 mois à 40 °C et 75 % d'humidité relative et le profil de dissolution au moment de la fabrication étant inférieure ou égale à environ 5 %.
Arieli Dafna
Gold Tomer
Heenan Blaikie Llp
Teva Pharmaceutical Industries Ltd.
LandOfFree
Controlled release formulation of tolterodine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled release formulation of tolterodine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release formulation of tolterodine will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1515478